Bio Green Med Solution (BGMS) Accounts Payables (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Accounts Payables of $256000.0 for Q1 2026, up 124.56% year-over-year from $114000.0 in Q1 2025, and down 58.51% quarter-over-quarter from $617000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Accounts Payables (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Accounts Payables for 17 consecutive years, with $256000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 124.56% year-over-year to $256000.0; the TTM figure through Mar 2026 stood at $256000.0 (up 124.56% YoY), while the FY2025 annual figure was $617000.0, down 86.58% from the prior year.
- Accounts Payables declined to $256000.0 in Q1 2026 per BGMS's latest filing, from $617000.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $5.2 million in Q1 2024 and bottomed at $114000.0 in Q1 2025.
- Historically, Accounts Payables has averaged $2.3 million across 5 years, with a median of $2.2 million in 2022.
- Annual changes were most pronounced in 2022 — Accounts Payables surged 227.21% — and 2025, when it plunged 97.81%.
- Bio Green Med Solution's Accounts Payables stood at $2.6 million in 2022, then soared by 38.34% to $3.5 million in 2023, then climbed by 29.81% to $4.6 million in 2024, then plunged by 86.58% to $617000.0 in 2025, then slumped by 58.51% to $256000.0 in 2026.
- Business Quant data shows BGMS's Accounts Payables at $256000.0 in Q1 2026, $617000.0 in Q4 2025, and $468000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | 167.00 Mn |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | 88.42 Mn |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 470.30 Mn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 35.57 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | 189,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 189,000.00 |
| Mar 31, 2026 | 256,000.00 |
| Dec 31, 2025 | 617,000.00 |
| Sep 30, 2025 | 468,000.00 |
| Jun 30, 2025 | 221,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Dec 31, 2024 | 4.60 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 4.74 Mn |
| Mar 31, 2024 | 5.20 Mn |
| Dec 31, 2023 | 3.54 Mn |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 2.17 Mn |
| Mar 31, 2023 | 2.51 Mn |
| Dec 31, 2022 | 2.56 Mn |
| Sep 30, 2022 | 983,000.00 |
| Jun 30, 2022 | 2.21 Mn |
| Mar 31, 2022 | 2.85 Mn |
| Dec 31, 2021 | 2.12 Mn |
| Sep 30, 2021 | 1.52 Mn |